This edition of the HDYO Research Video Series explores the HD Buzz article looking at the outcomes of the SELECT-HD clinical trial with encouraging news for this allele-selective huntingtin lowering therapy.
To read the complete HD Buzz article, click here: https://en.hdbuzz.net/371
HDYO Research Video Series is sponsored by Roche, Sage Therapeutics, Teva Pharmaceuticals, uniQure, Wave Life Sciences, Neurocrine Biosciences and the Griffin Foundation.